Cellebrite DI Sees FY2026 Sales $565.000M-$571.000M vs $554.864M Est
Benzinga Newsdesk 8 months ago
NewsGuidance
Cellebrite DI (NASDAQ:CLBT) sees FY2026 sales of $565.000 million-$571.000 million vs $554.864 million analyst estimate.
Cellebrite DI (NASDAQ:CLBT) sees FY2026 sales of $565.000 million-$571.000 million vs $554.864 million analyst estimate.